Exercise duRing Active Surveillance for prostatE cancer—the ERASE trial: a study protocol of a phase II randomised controlled trial

INTRODUCTION: Active surveillance (AS) is the preferred primary treatment strategy for men with low-risk clinically localised prostate cancer (PCa); however, the majority of these men still receive radical treatment within 10 years due to disease progression and/or fear of cancer progression. Interv...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Dong-Woo, Fairey, Adrian S, Boulé, Normand G, Field, Catherine J, Courneya, Kerry S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615898/
https://www.ncbi.nlm.nih.gov/pubmed/31278095
http://dx.doi.org/10.1136/bmjopen-2018-026438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615898/
https://www.ncbi.nlm.nih.gov/pubmed/31278095
http://dx.doi.org/10.1136/bmjopen-2018-026438

Ejemplares similares